Dermatologic Manifestations of Zika Virus

Withdrawn

• Conditions: Zika Virus Symptoms and the Associated Exanthema

• Registration Number: NCT03229421
• Lead Sponsor: Northwestern University

Brief Summary

The purpose of this study is to determine whether any diagnostic patterns exist in the symptom presentation of Zika Virus.

Detailed Description

The study has both retrospective and prospective components. The retrospective review includes medical records with laboratory confirmed Zika Virus diagnosis and the prospective component will enroll adults presenting with febrile illness and rash and ask them to complete a survey about their symptoms. Diagnostic testing will be completed to confirm infection source.

Study Timeline

• Study Start: 2017-07-06
• Study First Submitted: 2017-07-18
• Study First Submitted QC: 2017-07-21
• Study First Posted: 2017-07-25
• Primary Completion: 2018-12-31
• Study Completion: 2018-12-31
• Status Verified: 2019-01
• Last Update Submitted: 2019-01-31
• Last Update Posted: 2019-02-04

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Adults aged 18 years and older presenting with febrile illness and rash

Read More

Exclusion Criteria

• Patients aged 17 years or younger

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of days with specific symptoms	20 minutes	Number of days reported experiencing specific symptoms due to Zika Virus infection and and associated characteristics such as location and intensity

Secondary Outcome Measures

Name	Time	Method
Frequency measures of initial clinical presentations	20 minutes	Frequency of reported symptoms at initial clinical presentation.

Trial Locations

Locations (1)

Pontificia Universidad Catolica Madre y Maestra, Departamento de Medicina; 🇩🇴 Santo Domingo, Illinois, Dominican Republic